Clindamycin Hydrochloride
- Product NDC
- 70934-329
- 11-digit product format
- 709340329
- Labeler code
- 70934
- Product ID
- 70934-329_d44ad4be-0b5a-b8bd-e053-2a95a90a7b64
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Clindamycin Hydrochloride
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. DBA Northwind Pharmaceuticals
- Application
- ANDA063083
- Marketing category
- ANDA
- Marketing start
- 2019-03-28
- Marketing end
- 0000-00-00
- Substance
- CLINDAMYCIN HYDROCHLORIDE
- Active strength
- 150 mg/1
- Pharmacologic classes
- Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [CS],Neuromuscular Blockade [PE]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70934-329-30 | 70934032930 | 30 CAPSULE in 1 BOTTLE, PLASTIC (70934-329-30) | 30 capsule | 2019-03-28 | 0000-00-00 | No | No | Current |